ID   GR-Mel-8
AC   CVCL_C498
DR   cancercelllines; CVCL_C498
DR   Cosmic; 2163845
DR   ESTDAB; ESTDAB-158
DR   Wikidata; Q54871659
RX   PubMed=23851445;
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61Arg (c.182A>G); ClinVar=VCV000013900; Zygosity=Unspecified (PubMed=23851445).
ST   Source(s): ESTDAB=ESTDAB-158
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 13
ST   D3S1358: 16,17
ST   D5S818: 11,14
ST   D7S820: 10,12
ST   FGA: 23.2,24
ST   TH01: 7,9.3
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 19-12-24; Version: 13
//
RX   PubMed=23851445; DOI=10.1158/1541-7786.MCR-13-0006;
RA   Dahl C., Christensen C., Jonsson G., Lorentzen A., Skjodt M.L.,
RA   Borg A., Pawelec G., Guldberg P.;
RT   "Mutual exclusivity analysis of genetic and epigenetic drivers in
RT   melanoma identifies a link between p14 ARF and RARbeta signaling.";
RL   Mol. Cancer Res. 11:1166-1178(2013).
//